Analyse de l'application BCN RC pour le 26 janvier

The Barcelona Risk Calculator (BCN-RC) of significant prostate cancer (sPCa) in prostate biopsies was developed based on two predictive models (PMs). One model (BCN-PM 1) is used to identify candidates for magnetic resonance imaging (MRI) to help avoid unnecessary imaging, while the other (BCN-PM 2) is used to select candidates for prostate biopsy. Disclaimer: This app is intended for use by healthcare professionals for clinical support purposes. It does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any medical decisions.